Arrhythmias & electrophysiologyCohort study

Insertable cardiac monitoring results in higher rates of atrial fibrillation diagnosis and oral anticoagulation prescription after ischaemic stroke

EuropacePublished

  • Retrospective cohort study
  • propensity-score matched 1:4

Authors' conclusion

Patients with an ischaemic stroke monitored with an ICM were almost three times more likely to be diagnosed with AF and to be prescribed OAC compared to patients who received ECM only.

Study context

Population
Medicare Fee-for-Service (FFS) beneficiaries hospitalized with ischaemic stroke in 2017–2019 who received an insertable cardiac monitor (ICM) or external cardiac monitor (ECM) within 3 months; no prior atrial fibrillation (AF), atrial flutter, cardiac devices or oral anticoagulant (OAC)matched cohort n = 2210
Participants
5,702 beneficiaries
Exposure
ICM vs ECM after ischaemic stroke
  • ICMn = 444
  • ECMn = 5,258reference
Outcome
AF detection and OAC initiation

Main finding

As reported in the abstract

ICM vs ECMHR
AF detection
2.88(95% CI 2.31–3.59)
OAC initiation
2.91(CI 2.28–3.72)

Observational data: associations, not effects.

Original publication

Insertable cardiac monitoring results in higher rates of atrial fibrillation diagnosis and oral anticoagulation prescription after ischaemic stroke. Europace. Published 25 July 2023. doi:10.1093/europace/euad212

Summarised from the published abstract; every number is checked against it